14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
FORR vs SBC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over Forrester Research Inc (FORR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FORR carries a Unified Composite Score of 57.2/100 (HOLD) at $8.64 (9.6x Forward P/E, 0.3% operating margin), whereas SBC carries 47.2/100 (HOLD) at $5.17 (9.0x Forward P/E, 39.9% operating margin).
Composite vs. Pillar Nuance: While FORR currently prints a higher short-term Unified Composite Score (57.2/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 0.3% operating margin) and revenue trajectory (+35.1% vs. -8.7% YoY).
Technical & Structure Timing Caution: FORR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4); meanwhile SBC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FORR vs SBC. Trailing 12-month operating profitability (FORR 0.3% vs SBC 39.9%) and valuation multiples (FORR 9.6x vs SBC 9.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Consulting Services value chain with $159.0M market capitalization and 0.3% operating margin.
OpEx & R&D Reinvestment56.6% of Rev ($211M)
90D Engineering Disclosures0 Published
SBC Moat ProfileHigh-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $574.4M market capitalization and 39.9% operating margin.
OpEx & R&D Reinvestment32.3% of Rev ($61M)
90D Engineering Disclosures0 Published
Investor FAQ FORR vs SBC Key Questions & Quantitative Answers
As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over Forrester Research Inc (FORR) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FORR carries a Unified Composite Score of 57.2/100 (HOLD) at $8.64 (9.6x Forward P/E, 0.3% operating margin), whereas SBC carries 47.2/100 (HOLD) at $5.17 (9.0x Forward P/E, 39.9% operating margin). Composite vs. Pillar Nuance: While FORR currently prints a higher short-term Unified Composite Score (57.2/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 0.3% operating margin) and revenue trajectory (+35.1% vs. -8.7% YoY). Technical & Structure Timing Caution: FORR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4); meanwhile SBC trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SBC leads the Growth & Scale pillar: FORR posts -8.7% YoY revenue growth and +290.0% YoY earnings growth on $373M TTM revenue (56.9% gross margin, 0.3% operating margin), compared with SBC at +35.1% YoY revenue growth and +22.4% YoY earnings growth on $190M TTM revenue (72.2% gross margin, 39.9% operating margin). On trailing 12-month operating scale, FORR generates $373M in USD-normalized revenue versus $190M for SBC. In operating R&D and SG&A reinvestment, FORR deploys 56.6% of Rev ($211M) (0 90-day corporate R&D disclosures) versus 32.3% of Rev ($61M) (0 disclosures) for SBC.
SBC screens cheaper on headline valuation multiples. FORR trades at 9.6x Forward P/E, 14.1x Trailing P/E, 1.01x PEG, and 0.4x EV/Revenue (3.2% EBITDA margin), whereas SBC trades at 9.0x Forward P/E, 11.0x Trailing P/E, 2.40x PEG, and 3.0x EV/Revenue (41.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FORR (-33.6% ROE) versus SBC (19.3% ROE) capital efficiency.
In options market volatility and institutional positioning, FORR carries 133.6% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 54% Vol realized risk). By comparison, SBC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 159% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.